Patents by Inventor Corinna Mauth

Corinna Mauth has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10238775
    Abstract: Sliceable bone repair material is a porous block-shaped scaffold containing a hydrogel, wherein the hydrogel is formed by Michael type addition of at least two precursor molecules. Said scaffold is made of a synthetic ceramic material and has interconnected macropores having a diameter above 100 ?m. In addition said scaffold has a total porosity of 60 to 80%. The total volume of the hydrogel is smaller than the total volume of the interconnected macropores.
    Type: Grant
    Filed: March 31, 2017
    Date of Patent: March 26, 2019
    Assignee: STRAUMANN HOLDING AG
    Inventors: Corinna Mauth, Aaldert-Rens Molenberg
  • Patent number: 10098983
    Abstract: Sliceable bone repair material is a porous block-shaped scaffold containing a hydrogel, wherein the hydrogel is formed by Michael type addition of at least two precursor molecules. Said scaffold is made of a synthetic ceramic material and has interconnected macropores having a diameter above 100 ?m. In addition said scaffold has a total porosity of 80 to 95%. The total volume of the hydrogel is smaller than the total volume of the interconnected macropores.
    Type: Grant
    Filed: March 31, 2017
    Date of Patent: October 16, 2018
    Assignees: STRAUMANN HOLDING AG, CAM BIOCERAMICS B.V.
    Inventors: Corinna Mauth, Aaldert-Rens Molenberg
  • Publication number: 20170203000
    Abstract: Sliceable bone repair material is a porous block-shaped scaffold containing a hydrogel, wherein the hydrogel is formed by Michael type addition of at least two precursor molecules. Said scaffold is made of a synthetic ceramic material and has interconnected macropores having a diameter above 100 ?m. In addition said scaffold has a total porosity of 80 to 95%. The total volume of the hydrogel is smaller than the total volume of the interconnected macropores.
    Type: Application
    Filed: March 31, 2017
    Publication date: July 20, 2017
    Applicants: STRAUMANN HOLDING AG, CAM BIOCERAMICS B.V.
    Inventors: Corinna MAUTH, Aaldert-Rens MOLENBERG
  • Publication number: 20170203008
    Abstract: Sliceable bone repair material is a porous block-shaped scaffold containing a hydrogel, wherein the hydrogel is formed by Michael type addition of at least two precursor molecules. Said scaffold is made of a synthetic ceramic material and has interconnected macropores having a diameter above 100 ?m. In addition said scaffold has a total porosity of 60 to 80%. The total volume of the hydrogel is smaller than the total volume of the interconnected macropores.
    Type: Application
    Filed: March 31, 2017
    Publication date: July 20, 2017
    Applicant: STRAUMANN HOLDING AG
    Inventors: Corinna MAUTH, Aaldert-Rens MOLENBERG
  • Publication number: 20150032221
    Abstract: Sliceable bone repair material is a porous block-shaped scaffold containing a hydrogel, wherein the hydrogel is formed by Michael type addition of at least two precursor molecules. Said scaffold is made of a synthetic ceramic material and has interconnected macropores having a diameter above 100 ?m. In addition said scaffold has a total porosity of 80 to 95%. The total volume of the hydrogel is smaller than the total volume of the interconnected macropores.
    Type: Application
    Filed: February 12, 2013
    Publication date: January 29, 2015
    Inventors: Corinna Mauth, Aaldert-Rens Molenberg
  • Publication number: 20150025651
    Abstract: Sliceable bone repair material is a porous block-shaped scaffold containing a hydrogel, wherein the hydrogel is formed by Michael type addition of at least two precursor molecules. Said scaffold is made of a synthetic ceramic material and has interconnected macropores having a diameter above 100 ?m. In addition said scaffold has a total porosity of 60 to 80%. The total volume of the hydrogel is smaller than the total volume of the interconnected macropores.
    Type: Application
    Filed: February 12, 2013
    Publication date: January 22, 2015
    Inventors: Corinna Mauth, Aaldert-Rens Molenberg
  • Patent number: 8466101
    Abstract: Pharmaceutical, dental and/or cosmetic composition consisting of purified Enamel Matrix Derivative (EMD) proteins which have a molecular weight between 1 and 55 kDa, formulated in a suitable pharmaceutical carrier. The composition is depleted of proteins which have a molecular weight between 56 and 160 kDa and an iso-electric point between 3-10. The purified Enamel Matrix Derivative (EMD) proteins are depleted of proteinase inhibitors, such as ?1-antichymotrypsin and/or Fetuin A. The composition is preferably used for promoting and/or inducing regeneration of hard tissue, tissue mineralization, bone growth and/or bone regrowth, regeneration of dentin, cementogenesis, and/or binding between parts of living mineralized tissue, for bonding of a piece of living mineralized tissue to a bonding site on a piece of other living tissue, for endorsing binding between hard tissues, and/or for filling a mineralized wound cavity and/or tissue defect following from a procedure and/or trauma.
    Type: Grant
    Filed: October 29, 2010
    Date of Patent: June 18, 2013
    Assignee: Straumann Holding AG
    Inventors: P. Mark Bartold, Peter S. Zilm, Corinna Mauth, Ruzica Ranevski
  • Publication number: 20120309685
    Abstract: Pharmaceutical, dental and/or cosmetic composition consisting of purified Enamel Matrix Derivative (EMD) proteins which have a molecular weight between 1 and 55 kDa, formulated in a suitable pharmaceutical carrier. The composition is depleted of proteins which have a molecular weight between 56 and 160 kDa and an iso-electric point between 3-10. The purified Enamel Matrix Derivative (EMD) proteins are depleted of proteinase inhibitors, such as ?1-antichymotrypsin and/or Fetuin A. The composition is preferably used for promoting and/or inducing regeneration of hard tissue, tissue mineralization, bone growth and/or bone regrowth, regeneration of dentin, cementogenesis, and/or binding between parts of living mineralized tissue, for bonding of a piece of living mineralized tissue to a bonding site on a piece of other living tissue, for endorsing binding between hard tissues, and/or for filling a mineralized wound cavity and/or tissue defect following from a procedure and/or trauma.
    Type: Application
    Filed: October 29, 2010
    Publication date: December 6, 2012
    Applicant: Straumann Holding AG
    Inventors: P. Mark Bartold, Peter S. Zilm, Corinna Mauth, Ruzica Ranevski
  • Publication number: 20110312891
    Abstract: Isolated active compound of a naturally occurring fraction of Enamel Matrix Derivatives (EMD), having at least one of each two N-terminal polypeptide fragments of amelogenin, which are at least 95% identical to an amino acid sequence as shown in SEQ. ID. No:1 and/or 2. The invention relates to the use of said isolated active compound of a fraction and/or of the fraction itself, and/or the at least one of each two polypeptide fragments for use as a medicament and/or for the manufacture of a pharmaceutical composition for a variety of different medical indications such as inducing and/or promoting cementogenesis, bone growth and/or binding between parts of living mineralised tissue, for bonding of a piece of living mineralised tissue to a bonding site on a piece of other living tissue, for endorsing binding between hard tissues, for inducing regeneration of dentin, and/or for filling a mineralized wound cavity and/or tissue defect following from a procedure and/or trauma.
    Type: Application
    Filed: June 29, 2009
    Publication date: December 22, 2011
    Applicant: Straumann Holding AG
    Inventors: Stina Gestrelius, Michel Dard, Ruzica Ranevski, S. Petter Lyngstadaas, Corinna Mauth